Arquivos do dia: Março 9, 2022

Estudo randomizado | Glicocorticoide inalatório de demanda reduz exacerbações graves em adultos negros e latinos com asma moderada a grave.

9 Mar, 2022 | 13:56h

Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comentário: Patient-centered intervention improved asthma outcomes for Black and Latinx adults – Brigham and Women’s Hospital

---

Estudo randomizado | Inibidor de SGLT2 empaglifozina em pacientes internados com insuficiência cardíaca aguda.

9 Mar, 2022 | 13:54h

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial – Nature Medicine

---

Diretriz da ACR/Vasculitis Foundation para o tratamento da doença de Kawasaki.

9 Mar, 2022 | 13:53h

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease

---

Diretrizes de melhores práticas da ACS | Lesões na coluna.

9 Mar, 2022 | 13:52h

Spine Injury – American College of Surgeons

Comunicado de imprensa: New guidelines will help trauma centers treat spinal injury patients

---

Diretriz de posicionamento AAN | Diretriz clínica de cuidados neuropaliativos.

9 Mar, 2022 | 13:50h

Clinical Guidance in Neuropalliative Care: An AAN Position Statement – Neurology

---

Estudo randomizado | Em pacientes com choque hemorrágico relacionado a trauma recebendo cuidados pré-hospitalares, não houve benefício na ressuscitação com hemoderivados em comparação com o cloreto de sódio 0,9%.

9 Mar, 2022 | 13:49h

Resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care (RePHILL): a multicentre, open-label, randomised, controlled, phase 3 trial – The Lancet Haematology

Comentário convidado: Prehospital blood transfusion: who benefits? – The Lancet Haematology

 

Comentário no Twitter

NEW research—resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care: results of #RePHILL, a randomised, controlled, phase 3 trial #openaccess #EmergencyMedicine 🚑🩸https://t.co/Ci0lMMCryX pic.twitter.com/iWEtV12N1r

— The Lancet Haematology (@TheLancetHaem) March 8, 2022

 

---

SARS-CoV-2 levou a alterações na estrutura cerebral em pacientes do Biobank do Reino Unido.

9 Mar, 2022 | 13:48h

SARS-CoV-2 is associated with changes in brain structure in UK Biobank – Nature

Comentários:

Brain changes after COVID revealed by imaging – Nature

Even mild cases of COVID-19 can leave a mark on the brain, such as reductions in gray matter – a neuroscientist explains emerging research – The Conversation

Scans reveal how Covid may change the brain – BBC

---

Estudo de coorte | Trajetória de 1 ano das alterações cognitivas em sobreviventes idosos da COVID-19 em Wuhan, na China.

9 Mar, 2022 | 13:46h

One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China: A Longitudinal Cohort Study – JAMA Neurology

---

OMS afirma que doses de reforço da vacina contra COVID são necessárias, revertendo recomendação anterior.

9 Mar, 2022 | 13:45h

WHO says COVID boosters needed, reversing previous call – Associated Press

 

Comentário no Twitter

Who needs a booster? The @WHO reverses its position and supports "urgent and broad" 3-shot vaccination https://t.co/y5pyY9bJr7 @AP The evidence has supported that move for several months.
"Fully vaccinated" = 3-shots
(or confirmed infection-acquired immunity + 1 shot)

— Eric Topol (@EricTopol) March 8, 2022

 

---

Segurança das vacinas de mRNA administradas durante os primeiros 6 meses no programa de vacinação contra COVID-19 dos EUA.

9 Mar, 2022 | 13:44h

Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe – The Lancet Infectious Diseases

Comentários:

Large US study confirms most mRNA COVID-19 vaccine side effects are mild and temporary – Lancet

Covid vaccines not linked to deaths, major US study finds – BBC

Most mRNA COVID vaccine adverse events mild, transient – CIDRAP

---